Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 1

Status

Terminated 3Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 5NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Sarcoma 2Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 106Leukemia 98Lymphoma 79Burkitt Lymphoma 52Leukemia, Myeloid, Acute 51Myelodysplastic Syndromes 41Lymphoma, Non-Hodgkin 41Lymphoma, Large B-Cell, Diffuse 35Lymphoma, Mantle-Cell 33Leukemia, Lymphocytic, Chronic, B-Cell 32Leukemia, Myeloid, Accelerated Phase 30Hodgkin Disease 29Lymphoma, Follicular 28Blast Crisis 27Graft vs Host Disease 26Congenital Abnormalities 26Myeloproliferative Disorders 25Leukemia, Myeloid, Chronic-Phase 25Multiple Myeloma 24Breast Neoplasms 23Lymphoma, B-Cell, Marginal Zone 22Leukemia, Myelomonocytic, Chronic 22Lymphoma, Large-Cell, Immunoblastic 21Primary Myelofibrosis 16Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 16Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 16Recurrence 15Neoplasms, Plasma Cell 15Dendritic Cell Sarcoma, Interdigitating 15Anemia, Refractory, with Excess of Blasts 15

Interventions

Oxaliplatin 67Capecitabine 60Fluorouracil 58Bevacizumab 54Gemcitabine 51Paclitaxel 50Leucovorin 50Irinotecan 40Docetaxel 39Carboplatin 39Cisplatin 38pembrolizumab 37Nivolumab 37Cetuximab 35Sunitinib 25Trastuzumab 24Radiosurgery 24Radiotherapy 21Doxorubicin 21Cyclophosphamide 21Panitumumab 20Drug Therapy 19Pemetrexed 18Everolimus 18Sorafenib 17Interleukin-2 16Fulvestrant 16Albumin-Bound Paclitaxel 16atezolizumab 15Erlotinib Hydrochloride 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Neoplasm Metastasis × Methotrexate × Clear all
NCT07361133 2026-04-16

Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer

National Cancer Institute, Egypt

Phase 2 Not yet recruiting
120 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT07477457 2026-03-17

A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
45 enrolled
Sarcoma

Neoplasm Metastasis, Osteosarcoma

NCT00001880 2021-11-10

Stem Cell Transplantation for Metastatic Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
42 enrolled 11 charts

Graft vs Host Disease, Neoplasm Metastasis, Neoplasms

NCT03063983 2017-03-13

GLATO2017

Grupo de Apoio ao Adolescente e a Crianca com Cancer

Phase 2 Unknown
158 enrolled
Sarcoma

Neoplasm Metastasis, Osteosarcoma

NCT00952016 2016-10-14

MESH

Royal Marsden NHS Foundation Trust

Phase 2 Terminated
2 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01067989 2015-07-08

Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

HaEmek Medical Center, Israel

Phase 2 Terminated
22 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡